Investors Buy Shares of Clorox Company (The) (CLX) on Weakness

Traders bought shares of Clorox Company (The) (NYSE:CLX) on weakness during trading hours on Monday. $37.23 million flowed into the stock on the tick-up and $15.88 million flowed out of the stock on the tick-down, for a money net flow of $21.35 million into the stock. Of all companies tracked, Clorox Company (The) had the 20th highest net in-flow for the day. Clorox Company (The) traded down ($0.92) for the day and closed at $131.32

A number of research analysts have weighed in on CLX shares. Vetr upgraded Clorox Company (The) from a “hold” rating to a “buy” rating and set a $139.67 target price on the stock in a report on Monday, April 24th. Deutsche Bank AG restated a “hold” rating and issued a $137.00 price target (up previously from $126.00) on shares of Clorox Company (The) in a research note on Saturday, July 22nd. BMO Capital Markets restated a “buy” rating and issued a $136.00 price target on shares of Clorox Company (The) in a research note on Thursday, May 4th. Royal Bank Of Canada restated a “hold” rating and issued a $115.00 price target on shares of Clorox Company (The) in a research note on Wednesday, August 2nd. Finally, Zacks Investment Research downgraded Clorox Company (The) from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $129.05.

The firm’s 50-day moving average is $133.55 and its 200-day moving average is $134.12. The stock has a market cap of $17.78 billion, a PE ratio of 25.82 and a beta of 0.40.

Clorox Company (The) (NYSE:CLX) last released its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.04. The company had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.65 billion. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The firm’s quarterly revenue was up 2.9% on a year-over-year basis. During the same period in the prior year, the business earned $1.30 EPS. Equities analysts predict that Clorox Company will post $5.67 earnings per share for the current fiscal year.

Large investors have recently made changes to their positions in the stock. Nationwide Fund Advisors raised its stake in shares of Clorox Company (The) by 2.1% in the first quarter. Nationwide Fund Advisors now owns 36,264 shares of the company’s stock worth $4,889,000 after buying an additional 751 shares during the last quarter. Candriam Luxembourg S.C.A. raised its stake in shares of Clorox Company (The) by 21.2% in the first quarter. Candriam Luxembourg S.C.A. now owns 10,391 shares of the company’s stock worth $1,401,000 after buying an additional 1,815 shares during the last quarter. Wagner Bowman Management Corp raised its stake in shares of Clorox Company (The) by 13.1% in the first quarter. Wagner Bowman Management Corp now owns 2,512 shares of the company’s stock worth $338,000 after buying an additional 290 shares during the last quarter. Stewart & Patten Co. LLC raised its stake in shares of Clorox Company (The) by 0.7% in the first quarter. Stewart & Patten Co. LLC now owns 40,507 shares of the company’s stock worth $5,462,000 after buying an additional 300 shares during the last quarter. Finally, Oakbrook Investments LLC purchased a new stake in shares of Clorox Company (The) during the first quarter worth $229,000. Institutional investors and hedge funds own 69.83% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Investors Buy Shares of Clorox Company (The) (CLX) on Weakness” was originally posted by BNB Daily and is owned by of BNB Daily. If you are accessing this piece on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.baseball-news-blog.com/2017/08/19/investors-buy-clorox-company-the-clx-on-weakness-updated-updated-updated.html.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply